[Omaron in the treatment of vertebrobasilar insufficiency].
The study aimed at evaluation of tolerability, safety and clinical efficacy of omaron in the treatment of vertebrobasilar insufficiency (VBI). Forty patients with different stages of VBI have been examined. A diagnosis of VBI was based on the results of neurological study, ultrasonic dopplerography, electroencephalography, electrocardiography, brain MRI and CT examination. Neurological scales were used for assessment of neurological status and further data processing. The treatment with omaron resulted in significant clinical improvement and stabilization of the pathological process. The drug is well-tolerated by patients including those of older age groups.
Lobzin
S V
SV
Bodrova
T V
TV
Vasilenko
A V
AV
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D002936:Cinnarizine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004569:Electroencephalography; D005260:Female; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D010889:Piracetam / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018616:Ultrasonography, Doppler, Duplex; D014715:Vertebrobasilar Insufficiency / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D055815:Young Adult
D002121:Calcium Channel Blockers; D004338:Drug Combinations; D018696:Neuroprotective Agents; D002936:Cinnarizine; D010889:Piracetam